Doctor of Optometry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

L Besler

Optometrist Overland Park, KS Doctor of Optometry

NPI 1447235213 CMS profile 375738

5703 W 95Th St, Overland Park, KS 66207

Open in the dashboard

General payments

$4,209

130 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, L Besler of Overland Park, KS is reported in the CMS Open Payments database as having received $4,209 across 130 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 91st percentile of Optometrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $610 20
2024 General $263 14
2023 General $174 10
2022 General $560 20
2021 General $531 26
2020 General $647 19
2019 General $1,423 21

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • L Besler
  • Optometrist median
  • Middle half of Optometrist
  • National median

In program year 2025, general payments to L Besler were reported at $610. Among 35,373 Optometrist profiles paid that year, the median was $204 and the middle half received between $87 and $464.

Show as a table
Year L Besler Optometrist median Middle half National median
2019 $1,423 $159 $67–$371 $163
2020 $647 $72 $29–$165 $114
2021 $531 $125 $46–$292 $132
2022 $560 $162 $66–$374 $149
2023 $174 $177 $72–$406 $160
2024 $263 $188 $77–$427 $164
2025 $610 $204 $87–$464 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Alcon Vision LLC $1,569 20 payments
  2. Allergan Inc. $566 24 payments
  3. Johnson & Johnson Vision Care, Inc. $352 19 payments
  4. Bausch & Lomb Americas Inc. $315 11 payments
  5. Bausch & Lomb, a division of Bausch Health US, LLC $301 5 payments
  6. Oyster Point Pharma, Inc. $277 14 payments
  7. Sun Pharmaceutical Industries Inc. $233 11 payments
  8. RxSight Inc $123 1 payment
  9. CooperVision Inc. $117 6 payments
  10. Novartis Pharmaceuticals Corporation $91 6 payments
  11. Other $266 13 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,385 127 payments
  2. Travel and Lodging $823 3 payments
Products named General payments · program years 2019–2025
  1. DAILIES $1,230 13 payments
  2. AIR OPTIX $646 3 payments
  3. Acuvue $290 15 payments
  4. RESTASIS $274 11 payments
  5. Cequa $233 11 payments
  6. TYRVAYA $180 9 payments
  7. ULTRA $178 4 payments
  8. VYZULTA $178 4 payments
  9. BIOTRUE ONE DAY $159 3 payments
  10. VUITY $159 5 payments
  11. Other $1,760 70 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

130 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Optometrist in Kansas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record